All news
-
13 Mar 2023
STEM-PD : A bench-to-bedside story by MultiPark researchers
After a decade of protocol development and preparations, MultiPark researchers have finally launched the clinical trial. Recently, dopamine-producing cells generated from embryonic...
-
8 Mar 2023
Electrodes grown in the brain
The boundaries between biology and technology are becoming blurred. Researchers at Linköping, Lund, and Gothenburg universities in Sweden have successfully grown electrodes in livi...
-
28 Feb 2023
First patient receives milestone stem cell-based transplant for Parkinson’s Disease
On 13th of February, a transplant of stem cell-derived nerve cells was administered to a person with Parkinson’s at Skåne University Hospital, Sweden. The product has been develope...
-
10 Feb 2023
Does Alzheimer’s disease start inside neurons? – PhD interview with Tomas Roos
The aggregation of the protein Amyloid-beta (Abeta) into plaques outside the nerve cells has been recognized in patients with Alzheimer’s disease since 1905. But eliminating the pl...
-
3 Feb 2023
Huntington’s metabolic dysfunctions – PhD interview with Elna Dickson
Huntington's disease is known as the "dance disease" due to the patient's characteristic motor symptoms. However, Elna Dickson's Ph.D. project shows that the disease also leads to ...
-
13 Jan 2023
Cognitive disease beyond the brain – PhD interview with Keivan Javanshiri
Keivan Javanshiri’s Ph.D. project explores cardiac and vascular pathologies in Lewy body dementia and Alzheimer's disease. January 20, he defends his thesis. Here, he shares the mo...
-
12 Jan 2023
Nerve cells could transform the treatment of Parkinson’s
At the end of October 2022, the Swedish Medical Products Agency gave the go-ahead for a clinical trial of the stem cell-based therapy STEM-PD for the treatment of Parkinson’s disea...
-
10 Jan 2023
Why dopamine receptor type matters – PhD interview with Katrine Skovgård
Katrine Skovgård’s Ph.D. project sheds light on the dysfunctions in the brain through which dopaminergic pharmacotherapies for Parkinson’s disease affect motor behaviors. January 1...
-
3 Jan 2023
Optimal blood tests for development of new therapies of Alzheimer’s disease
A new study have identified which blood tests are best at detecting Alzheimer’s disease during the earliest stages, and also another blood test that is optimal for detecting releva...
-
21 Dec 2022
MultiPark – Closing the circle of 2022 and looking forward to 2023
We ended the MultiPark year in December as we started it in January: with a MultiPark Retreat! The December retreat was our first big meeting IRL after the pandemic, and it turned ...
-
14 Dec 2022
Molecular signaling in neurodegenerative disorders – A special interest group
MultiPark’s new special interest groups (SIGs) address essential scientific and technological needs and provide opportunities for professional development and network formation to ...
-
2 Dec 2022
Walking with neurodegeneration – PhD interview with Magnus Lindh-Rengifo
Walking is probably more cognitively demanding than you think. Magnus Lindh-Rengifo defends his thesis about walking aspects in neurodegenerative disorders on December 16. Read abo...
-
29 Nov 2022
The brain's immune cells can be triggered to slow down Alzheimer's disease
The brain's big-eating immune cells can slow down the progression of Alzheimer's disease. This is shown by a study that is now published in Nature Aging.
-
23 Nov 2022
The glymphatic system in PD – PhD interview with Roberta Battistella
The glymphatic system clears waste products from the brain. Roberta Battistella defends her thesis about the role of this system in Parkinson’s disease on December 1. Here, she tel...
-
22 Nov 2022
Brain Circuit Analysis – A special interest group
MultiPark’s backbone for research interactions is about to be reorganized. The 13 new special interest groups (SIGs) address essential scientific and technological needs and provid...
-
17 Nov 2022
Alzheimer's disease can be diagnosed before symptoms emerge
A large study led by Lund University in Sweden has shown that people with Alzheimer's disease can now be identified before they experience any symptoms. It is now also possible to ...
-
7 Nov 2022
MultiPark researcher with Bill Gates in Brussels
MultiPark’s scientists conduct world-leading research in biomarkers for Alzheimer’s disease, led by Professor Oskar Hansson at the memory clinic at Skåne University Hospital. He re...
-
28 Oct 2022
Modelling Parkinson’s disease – PhD interview with Matilde Negrini
Matilde Negrini’s thesis project has been to develop and characterize a rat model of Parkinson’s disease. November 4, she defends her thesis. Here, she talks about her project and ...
-
24 Oct 2022
Does the Mediterranean diet really decrease your risk of dementia?
Numerous studies have suggested that eating a healthy diet may reduce a person’s risk of dementia. A new study from one of MultiPark's research groups, published in Neurology, shed...